Screener
CONMED CNMD Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Accrued compensation and benefits | (11,706) | 930 |
| Other assets | (16,683) | (9,874) |
| Other liabilities | (6,853) | (4,324) |
| Net cash provided by operating activities | 50,567 | 70,668 |
| Cash flows from investing activities: | ||
| Proceeds from sale of product offerings | 21,500 | — |
| Purchases of property, plant and equipment | (5,826) | (9,508) |
| Other | — | 850 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's operating cash flow?
- CONMED (CNMD) reported operating cash flow of $37.1M in Q2 2026.
- How has CONMED's operating cash flow changed year-over-year?
- CONMED's operating cash flow increased by 27.3% year-over-year, from $29.13M to $37.1M.
- What is the long-term trend for CONMED's operating cash flow?
- Over 3 years (2021 to 2025), CONMED's operating cash flow has grown at a 15.2% compound annual growth rate (CAGR), from $111.77M to $170.69M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about CONMED's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude